JP2013526536A5 - - Google Patents

Download PDF

Info

Publication number
JP2013526536A5
JP2013526536A5 JP2013510285A JP2013510285A JP2013526536A5 JP 2013526536 A5 JP2013526536 A5 JP 2013526536A5 JP 2013510285 A JP2013510285 A JP 2013510285A JP 2013510285 A JP2013510285 A JP 2013510285A JP 2013526536 A5 JP2013526536 A5 JP 2013526536A5
Authority
JP
Japan
Prior art keywords
azetidin
pyrazin
quinoline
quinolin
methanone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013510285A
Other languages
English (en)
Japanese (ja)
Other versions
JP5702855B2 (ja
JP2013526536A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/036148 external-priority patent/WO2011143365A1/en
Publication of JP2013526536A publication Critical patent/JP2013526536A/ja
Publication of JP2013526536A5 publication Critical patent/JP2013526536A5/ja
Application granted granted Critical
Publication of JP5702855B2 publication Critical patent/JP5702855B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013510285A 2010-05-13 2011-05-11 Pde10阻害剤として有用な窒素複素環化合物 Expired - Fee Related JP5702855B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33452510P 2010-05-13 2010-05-13
US61/334,525 2010-05-13
PCT/US2011/036148 WO2011143365A1 (en) 2010-05-13 2011-05-11 Nitrogen heterocyclic compounds useful as pde10 inhibitors

Publications (3)

Publication Number Publication Date
JP2013526536A JP2013526536A (ja) 2013-06-24
JP2013526536A5 true JP2013526536A5 (cg-RX-API-DMAC7.html) 2014-04-03
JP5702855B2 JP5702855B2 (ja) 2015-04-15

Family

ID=44278966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013510285A Expired - Fee Related JP5702855B2 (ja) 2010-05-13 2011-05-11 Pde10阻害剤として有用な窒素複素環化合物

Country Status (26)

Country Link
US (3) US8957073B2 (cg-RX-API-DMAC7.html)
EP (1) EP2569300A1 (cg-RX-API-DMAC7.html)
JP (1) JP5702855B2 (cg-RX-API-DMAC7.html)
KR (1) KR101564806B1 (cg-RX-API-DMAC7.html)
CN (1) CN103221404B (cg-RX-API-DMAC7.html)
AR (1) AR081627A1 (cg-RX-API-DMAC7.html)
AU (1) AU2011253057B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012029026A2 (cg-RX-API-DMAC7.html)
CA (1) CA2798490A1 (cg-RX-API-DMAC7.html)
CL (1) CL2012003178A1 (cg-RX-API-DMAC7.html)
CO (1) CO6630189A2 (cg-RX-API-DMAC7.html)
CR (1) CR20120635A (cg-RX-API-DMAC7.html)
EA (1) EA201291236A1 (cg-RX-API-DMAC7.html)
IL (1) IL222898A (cg-RX-API-DMAC7.html)
MA (1) MA34300B1 (cg-RX-API-DMAC7.html)
MX (1) MX2012013130A (cg-RX-API-DMAC7.html)
NZ (1) NZ603876A (cg-RX-API-DMAC7.html)
PE (1) PE20130576A1 (cg-RX-API-DMAC7.html)
PH (1) PH12012502212A1 (cg-RX-API-DMAC7.html)
SG (1) SG185515A1 (cg-RX-API-DMAC7.html)
TN (1) TN2012000530A1 (cg-RX-API-DMAC7.html)
TW (1) TW201206902A (cg-RX-API-DMAC7.html)
UA (1) UA109438C2 (cg-RX-API-DMAC7.html)
UY (1) UY33382A (cg-RX-API-DMAC7.html)
WO (1) WO2011143365A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201208510B (cg-RX-API-DMAC7.html)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2569302A1 (en) 2010-05-13 2013-03-20 Amgen, Inc Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
US8952037B2 (en) 2010-05-13 2015-02-10 Amgen Inc. Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
JP5702855B2 (ja) * 2010-05-13 2015-04-15 アムジエン・インコーポレーテツド Pde10阻害剤として有用な窒素複素環化合物
MX2012013128A (es) 2010-05-13 2013-03-20 Amgen Inc Compuestos heterociclicos de nitrogeno como inhibidores de la fosfodiesterasa 10.
EP2675791B1 (en) 2011-02-18 2016-02-17 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9073947B2 (en) * 2011-06-10 2015-07-07 Merck Patent Gmbh Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
US8623860B2 (en) * 2011-12-30 2014-01-07 Boehringer Ingelheim International Gmbh Azetidine derivatives, pharmaceutical compositions and uses thereof
TW201348231A (zh) * 2012-02-29 2013-12-01 Amgen Inc 雜雙環化合物
CA2872989A1 (en) * 2012-05-09 2013-11-14 Zoetis Llc Azetidine derivatives as antiparasitic agents
AR091436A1 (es) 2012-06-14 2015-02-04 Amgen Inc Compuestos de azetidina y piperidina utiles como inhibidores de pde10
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US8987461B2 (en) 2012-12-06 2015-03-24 Quanticel Pharmaceuticals, Inc. Histone demethylase inhibitors
US20150374687A1 (en) * 2013-02-07 2015-12-31 Merck Patent Gmbh Substituted quinoxaline derivatives and their use as positive allosteric modulators of mglur4
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
US9527835B2 (en) 2014-02-13 2016-12-27 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
JP6602779B2 (ja) 2014-02-13 2019-11-06 インサイト・コーポレイション Lsd1阻害剤としてのシクロプロピルアミン類
US9493442B2 (en) 2014-02-13 2016-11-15 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
CN106164066B (zh) 2014-02-13 2020-01-17 因赛特公司 作为lsd1抑制剂的环丙胺
CN106103421B (zh) * 2014-02-14 2019-04-09 武田药品工业株式会社 Gpr6的吡嗪调节剂
CN104016909B (zh) * 2014-04-03 2016-04-20 定陶县友帮化工有限公司 一种2-氨基-3-溴-5-氯吡啶的合成方法
CN104016911A (zh) * 2014-04-03 2014-09-03 定陶县友帮化工有限公司 一种2-氨基-3,5-二溴吡啶的合成方法
ES2842592T3 (es) * 2014-05-19 2021-07-14 Boehringer Ingelheim Animal Health Usa Inc Compuestos antihelmínticos
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
WO2016007727A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
TW201613925A (en) 2014-07-10 2016-04-16 Incyte Corp Imidazopyrazines as LSD1 inhibitors
US9695168B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
CA2959208C (en) 2014-08-29 2023-09-19 Tes Pharma S.R.L. Pyrimidine derivatives and their use as inhibitors of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase
US9855249B2 (en) 2014-10-02 2018-01-02 Flatley Discovery Lab, Llc Isoxazole compounds and methods for the treatment of cystic fibrosis
CN107660205B (zh) 2015-04-03 2021-08-27 因赛特公司 作为lsd1抑制剂的杂环化合物
WO2017009751A1 (en) 2015-07-15 2017-01-19 Pfizer Inc. Pyrimidine derivatives
EA035534B1 (ru) 2015-08-12 2020-06-30 Инсайт Корпорейшн Соли ингибитора lsd1
BR112018071585B1 (pt) 2016-04-22 2024-01-02 Incyte Corporation Formulações de um inibidor de lsd1, seus usos e método de preparação das mesmas
WO2017205425A1 (en) * 2016-05-24 2017-11-30 President And Fellows Of Harvard College Compounds for organic light emitting diode materials
WO2017210545A1 (en) 2016-06-02 2017-12-07 Cadent Therapeutics, Inc. Potassium channel modulators
PH12019501360B1 (en) * 2016-12-16 2024-02-21 Pfizer Glp-1 receptor agonists and uses thereof
PL3571193T3 (pl) 2017-01-23 2022-04-25 Cadent Therapeutics, Inc. Modulatory kanału potasowego
CN106957300A (zh) * 2017-04-12 2017-07-18 苏州汉德创宏生化科技有限公司 抗肿瘤杂环药物中间体2‑(3‑氮杂环丁基)吡啶二盐酸盐的合成方法
WO2019084338A1 (en) * 2017-10-25 2019-05-02 University Of South Florida DRUG-INDUCED ACTIVATION OF THE REELIN SIGNALING SYSTEM
TWI780246B (zh) 2017-10-27 2022-10-11 德商百靈佳殷格翰國際股份有限公司 Trpc 6抑制劑
US20210024498A1 (en) * 2017-12-26 2021-01-28 Mediconns (Shanghai) Biopharmaceutical Co., Ltd Tetrahydropyrrole compound, preparation method therefor, pharmaceutical composition containing same, and use thereof
PE20251292A1 (es) 2018-03-08 2025-05-14 Incyte Corp Compuestos diolicos de aminopirazina como inhibidores de pi3k-gamma
CA3045644C (en) * 2018-06-13 2024-01-16 Pfizer Inc. Glp-1 receptor agonists and uses thereof
EP3806855B1 (en) * 2018-06-15 2023-03-01 Pfizer Inc. Glp-1 receptor agonists and uses thereof
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
UY38394A (es) 2018-10-02 2020-04-30 Syngenta Participations Ag Compuestos de benceno y azina-amida activos como plaguicidas
BR112021007552A2 (pt) 2018-10-22 2021-07-27 Cadent Therapeutics, Inc. formas cristalinas de moduladores de canal de potássio
WO2020102216A1 (en) 2018-11-13 2020-05-22 Incyte Corporation Substituted heterocyclic derivatives as pi3k inhibitors
US11078204B2 (en) 2018-11-13 2021-08-03 Incyte Corporation Heterocyclic derivatives as PI3K inhibitors
WO2020102150A1 (en) 2018-11-13 2020-05-22 Incyte Corporation Heterocyclic derivatives as pi3k inhibitors
EA202191432A1 (ru) 2018-11-22 2021-10-14 Цилу Регор Терапьютикс Инк. Агонисты glp-1r и их применения
CN113165139B (zh) 2018-11-26 2023-06-09 京瓷株式会社 气体喷嘴和气体喷嘴的制造方法以及等离子体处理装置
AU2019387370A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
UY38623A (es) 2019-03-29 2020-10-30 Syngenta Crop Protection Ag Compuestos de diazina-amida activos como pesticidas
PE20220171A1 (es) 2019-04-05 2022-01-28 Syngenta Crop Protection Ag Compuestos de diazina-amida activos como pesticidas
AU2020272472A1 (en) 2019-04-11 2021-10-28 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds
EP3953344A4 (en) 2019-04-12 2023-08-09 Qilu Regor Therapeutics Inc. Glp-ir agonists and uses thereof
US10954221B2 (en) 2019-04-12 2021-03-23 Qilu Regor Therapeutics Inc. GLP-1R agonists and uses thereof
WO2020234726A1 (en) * 2019-05-20 2020-11-26 Pfizer Inc. Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
BR112022003375A2 (pt) 2019-08-23 2022-05-17 Syngenta Crop Protection Ag Compostos de pirazina-amida pesticidamente ativos
US12441719B2 (en) * 2019-09-12 2025-10-14 Disarm Therapeutics, Inc. Inhibitors of SARM1
AU2020369568B2 (en) 2019-10-25 2024-03-21 Gilead Sciences, Inc. GLP-1R modulating compounds
KR102344561B1 (ko) * 2019-11-15 2021-12-29 일동제약(주) Glp-1 수용체 작용제 및 이의 용도
WO2021138391A1 (en) 2019-12-30 2021-07-08 Tyra Biosciences, Inc. Indazole compounds
KR102863043B1 (ko) 2020-01-29 2025-09-23 길리애드 사이언시즈, 인코포레이티드 Glp-1r 조절 화합물
MX2022011349A (es) * 2020-03-18 2022-11-10 Lg Chemical Ltd Agonista del receptor de glp-1, composición farmacéutica que comprende el mismo, y método para preparar el mismo.
CN115279750B (zh) * 2020-03-18 2024-06-21 株式会社Lg化学 Glp-1受体激动剂、包含该激动剂的药物组合物及其制备方法
WO2022034146A1 (en) 2020-08-13 2022-02-17 Boehringer Ingelheim International Gmbh Treatment of cognitive impairement associated with schizophrenia
WO2022078927A1 (en) 2020-10-13 2022-04-21 Boehringer Ingelheim International Gmbh Process of reworking
US20240016959A1 (en) * 2020-11-19 2024-01-18 Cerecin Inc. Radiopharmaceutical ketone and dual tracer imaging in alzheimer's disease, cognitive impairment, and other conditions of altered cerebral metabolism
EP4247804A1 (en) 2020-11-20 2023-09-27 Gilead Sciences, Inc. Polyheterocyclic glp-1 r modulating compounds
CR20230325A (es) 2020-12-30 2023-12-11 Tyra Biosciences Inc Compuestos de indazol como inhibidores de cinasas
EP4304712A1 (en) 2021-03-11 2024-01-17 Gilead Sciences, Inc. Glp-1r modulating compounds
MX2023013492A (es) 2021-05-13 2024-02-29 Carmot Therapeutics Inc Moduladores de los receptores acoplados a proteinas g.
US20240287047A1 (en) 2021-06-09 2024-08-29 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds
CA3217423A1 (en) * 2021-06-16 2022-12-22 Jeffrey M. Schkeryantz Azetidinyl compounds comprising a carboxylic acid group for the treatment of neurodegenerative diseases
KR20240024935A (ko) 2021-06-18 2024-02-26 알리고스 테라퓨틱스 인코포레이티드 Pd-l1을 표적화하기 위한 방법 및 조성물
ES3049198T3 (en) 2021-09-27 2025-12-15 Terns Pharmaceuticals Inc Benzimidazole carboxylic acids as glp-1r agonists
IL312364A (en) 2021-10-25 2024-06-01 Luehr Gary W Compounds as GLP-1R agonists
JP2025503422A (ja) 2021-12-16 2025-02-04 アリゴス セラピューティクス インコーポレイテッド Pd-l1を標的とするための方法及び組成物
PE20250741A1 (es) 2022-02-23 2025-03-13 Terns Pharmaceuticals Inc Compuestos como agonistas de glp-1r
TWI866545B (zh) * 2022-10-20 2024-12-11 南韓商東亞St股份有限公司 氮雜環丁烷基苯并唑化合物及其等作為mer及axl抑制劑的用途
TW202506131A (zh) 2023-04-07 2025-02-16 美商拓臻製藥公司 GLP-1R及THRβ激動劑之組合以及其使用方法
WO2025147609A1 (en) * 2024-01-05 2025-07-10 Dewpoint Therapeutics, Inc. Amino quinoline compounds and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
HN2002000266A (es) 2001-09-24 2003-11-16 Bayer Corp Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad.
WO2003101927A1 (en) * 2002-05-31 2003-12-11 Proteotech, Inc. Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
CA2501539A1 (en) 2002-10-17 2004-04-29 Amgen Inc. Benzimidazole derivatives and their use as vanilloid receptor ligands
JP2007508241A (ja) 2003-07-31 2007-04-05 バイエル・フアーマシユーチカルズ・コーポレーシヨン Pde10a阻害剤を用いる糖尿病および関連障害の処置方法
GB0325287D0 (en) 2003-10-29 2003-12-03 Merck Sharp & Dohme Therapeutic agents
RU2417993C9 (ru) * 2004-05-18 2011-10-10 Шеринг Корпорейшн Замещенные 2-хинолилоксазолы, пригодные в качестве ингибиторов фдэ4
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
US20070072908A1 (en) 2005-06-08 2007-03-29 Japan Tobacco Inc. Heterocyclic compounds
WO2007076104A1 (en) * 2005-12-23 2007-07-05 Amgen Inc. Vanilloid receptor ligands and their use in treatments
BRPI0707223A2 (pt) * 2006-01-27 2011-04-26 Pfizer Prod Inc compostos de derivados de aminoftalazina
AU2008339572B2 (en) * 2007-12-21 2012-05-10 Astrazeneca Ab Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
CN102203074A (zh) 2008-06-20 2011-09-28 麦它波莱克斯股份有限公司 芳基gpr119激动剂及其用途
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
US20100204265A1 (en) 2009-02-09 2010-08-12 Genelabs Technologies, Inc. Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
US8937060B2 (en) 2009-05-12 2015-01-20 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
HUE024874T2 (en) 2009-09-03 2016-02-29 Bioenergenix Heterocyclic compounds for the inhibition of pask
MX2012003324A (es) * 2009-09-16 2012-04-30 Astellas Pharma Inc Compuesto de glicina.
EP2569302A1 (en) 2010-05-13 2013-03-20 Amgen, Inc Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
MX2012013128A (es) 2010-05-13 2013-03-20 Amgen Inc Compuestos heterociclicos de nitrogeno como inhibidores de la fosfodiesterasa 10.
JP5702855B2 (ja) * 2010-05-13 2015-04-15 アムジエン・インコーポレーテツド Pde10阻害剤として有用な窒素複素環化合物
US8952037B2 (en) 2010-05-13 2015-02-10 Amgen Inc. Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
AR091436A1 (es) 2012-06-14 2015-02-04 Amgen Inc Compuestos de azetidina y piperidina utiles como inhibidores de pde10

Similar Documents

Publication Publication Date Title
JP2013526536A5 (cg-RX-API-DMAC7.html)
JP5702855B2 (ja) Pde10阻害剤として有用な窒素複素環化合物
JP2025016684A5 (cg-RX-API-DMAC7.html)
CN103282360B (zh) Cxcr4受体拮抗剂
RU2484091C2 (ru) Производные изоксазоло-пиридина
RU2018142987A (ru) Положительные аллостерические модуляторы мускаринового ацетилхолинового рецептора m4
SI3177619T1 (en) 2- (morpholin-4-yl) -1,7-naphthyridines
HRP20231310T1 (hr) Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene
JP2015522002A5 (cg-RX-API-DMAC7.html)
JP2018529743A5 (cg-RX-API-DMAC7.html)
JP2012508776A5 (cg-RX-API-DMAC7.html)
JP2018524343A5 (cg-RX-API-DMAC7.html)
JP2018530557A5 (cg-RX-API-DMAC7.html)
JP2013525498A5 (cg-RX-API-DMAC7.html)
JP2010524984A5 (cg-RX-API-DMAC7.html)
RU2012136643A (ru) [5,6]- гетероциклическое соединение
HRP20210935T1 (hr) Spojevi 5-kloro-2-difluorometoksifenil pirazolopirimidina koji predstavljaju inhibitore jak
RU2014139601A (ru) Ингибиторы серин/треониновых киназ
RU2018115722A (ru) N-СУЛЬФОНИЛИРОВАННЫЕ ПИРАЗОЛО[3,4-b]ПИРИДИН-6-КАРБОКСАМИДЫ И СПОСОБ ИХ ПРИМЕНЕНИЯ
KR101995605B1 (ko) 키나아제 활성의 조절 인자로서 새로운 이미다졸 아민
CA2567662A1 (en) Compounds and compositions as protein kinase inhibitors
CA2642922A1 (en) Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
HRP20130054T1 (hr) Spojevi pirazina kao inhibitori fosfodiesteraze 10
JP2015500332A5 (cg-RX-API-DMAC7.html)
RU2012113593A (ru) Ингибиторы jak